Enantioselective protein binding of semotiadil and levosemotiadil determined by high-performance frontal analysis

Journal of Pharmaceutical and Biomedical Analysis

Volumn 15, Issue 9-10, 1997, Pages 1595-1601

  Rodriguez Rosas, Maria Esther ^a   Shibukawa, Akimasa ^a   Ueda, Kenji ^a   Nakagawa, Terumichi ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

1 acid glycoprotein; Albumin; High performance frontal analysis; HPLC; Levosemotiadil; Protein binding; Semotiadil

Indexed keywords

ALBUMIN; CALCIUM ANTAGONIST; HUMAN SERUM ALBUMIN; LEVOSEMOTIADIL; OROSOMUCOID; SESAMODIL FUMARATE; UNCLASSIFIED DRUG;

ANALYTIC METHOD; CONFERENCE PAPER; DRUG DETERMINATION; DRUG PROTEIN BINDING; ENANTIOMER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MATERIALS; PRIORITY JOURNAL; REPRODUCIBILITY;

BLOOD PROTEINS; CALCIUM CHANNEL BLOCKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; MOLECULAR STRUCTURE; ONLINE SYSTEMS; PROTEIN BINDING; SERUM ALBUMIN; SERUM ALBUMIN, BOVINE; STEREOISOMERISM; THIAZOLES;

EID: 0030923143     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0731-7085(96)02053-5     Document Type: Conference Paper

References (39)

1. M.C. Meyer and D.E. Guttman, J. Pharm. Sci., 57 (1968) 895-918.
2. J.J. Vallner, J. Pharm. Sci., 66 (1977) 477-465.
3. G.T. Tucker and M.S. Lennard, Pharmacol. Ther., 45 (1989) 309-329.
4. T. Noctor, in I.W. Wainer (Ed.). Drug Stereochemistry, Ch. 12., Dekker, NY, 1993.
5. T.C. Kwong, Clin. Chem. Acta, 151 (1985) 193-216.
6. G. Stark, K. Kasper, U. Stark, N. Miyawaki, M. Decrinis and H.A. Tritthart, Eur. J. Pharmacol., 286 (1995) 71-78.
7. M. Kageyama, T. Yanagisawa and N. Taira, Br. J. Pharmacol., 114 (1995) 1289-1295.
8. N. Miyawaki, T. Furuta, T. Shigei, H. Yamauchi and T. Iso, J. Cardiovasc. Pharmacol., 16 (1990) 769-775.
9. N. Teramoto, Jpn. J. Pharmacol., 61 (1993) 183-195.
10. K. Nishimura, N. Miyawaki, H. Yamauchi and T. Iso, Arzneimittelforschung., 40 (1990) 244-248.
11. M. Kageyama, K. Nishimura, T. Takada, N. Miyawaki and H. Yamauchi, J. Cardiovasc. Pharmacol., 17 (1991) 102-107.
12. T. Takada, N. Miyawaki, M. Kageyama, K. Matsuno, N. Ishida, H. Yamauchi and T. Iso, J. Cardiovasc. Pharmacol., 18 (1991) 855-862.
13. T. Mori, K. Irie and S. Ashida, Jpn. J. Pharmacol., 55 (Suppl. I) (1991) 328.
14. T. Mori, K. Irie, F. Ishii and S. Ashida, Jpn. J. Pharmacol., 52 (Suppl. I) (1990) 203.
15. I. Kodama, R. Suzuki, K. Maruyama and J. Toyama, Br. J. Pharmacol., 114 (1995) 503-509.
16. K. Nakayama, K. Morimoto, Y. Nazawa and Y. tanaka, J. Cardiovasc. Pharmacol., 20 (1992) 380-391.
17. N. Miyawaki, F. Yamazaki, T. Furuta, T. Shigei, H. Yamauchi, Drug Dev. Res., 22 (1991) 293-298.
18. S. Nagashima, T. Uematsu, T. Araki, M. Matsuzaki, H. Fukuchi and M. Nakashima, Naunyn-Schmiedeberg's Arch. Pharmacol., 345 (1992) 688-695.
19. A. Hirasawa, A. Haruno, T. Matsuzaki and K. Hashimoto, Jpn. Heart J., 33 (1992) 851-861.
20. M. Fukuchi, T. Uematsu, S. Nagashima and M. Nakashima, Naunyn-Schmiedeberg's Arch. Pharmacol., 341 (1990) 557-564.
21. Y. Hara and H. Nakaya, Br. J. Pharmacol., 116 (1995) 2750-2756.
22. A. Shibukawa, T. Nakagawa, N. Nishimura, M. Miyake and H. Tanaka, Chem. Pharm. Bull., 37 (1990) 443-447.
23. A. Shibukawa, N. Nishimura, K. Nomura, Y. Kuroda and T. Nakagawa, Chem. Pharm. Bull., 38 (1990) 443-447.
24. A. Shibukawa, M. Nagao, Y. Kuroda and T. Nakagawa, Anal. Chem., 62 (1990) 712-716.
25. N. Nishimura, A. Shibukawa and T. Nakagawa, Anal. Sci., 6 (1990) 355-359.
26. A. Shibukawa, A. Terakita, J. He and T. Nakagawa, J. Pharm. Sci., 81 (1992) 710-715.
27. A. Terakita, A. Shibukawa and T. Nakagawa, Anal. Sci., 9 (1993) 229-232.
28. A. Shibukawa, M. Nagao, A. Terakita, J. He and T. Nakagawa, J. Liq. Chromatogr., 16 (1993) 903-914.
29. A. Shibukawa, C. Nakao, T. Sawada, A. Terakita, N. Morokoshi and T. Nakagawa, J. Pharm. Sci., 83 (1994) 868-873.
30. A. Terakita, A. Shibukawa and T. Nakagawa, Anal. Sci., 10 (1994) 11-15.
31. A. Shibukawa, M. Kadohara, J. He, M. Nishimura, S. Naito and T. Nakagawa, J. Chromatogr. A, 694 (1995) 81-89.
32. A. Shibukawa, T. Sawada, C. Nakao, T. Izumi and T. Nakagawa, J. Chromatogr. A, 697 (1995) 337-343.
33. A. Shibukawa and T. Nakagawa, Anal. Chem., 68 (1995) 447-545.
34. T.C. Pinkerton, J. Chromatogr., 544 (1991) 13-23.
35. D.J. Anderson, Anal. Chem., 65 (1993) 434 R-443 R.
36. U. Kragh-Hansen, Pharmacol. Rev., 33 (1981) 17-53.
37. C. Lagerorantz, T. Larsson and I. Denfors, Comp. Biochem. Physiol., 69 C (1981) 375-378.
38. J.J. Lima, Drug Metab. Dispos., 16 (1988) 563-567.
39. S. Urien, Interaction of Drugs with Human Plasma Lipoproteins, In: J.P. Tillement and E. Lindenlaub (Eds.), Proc. Symp. Protein Binding and Drug Tansport, F.K. Schattauer Verlag, Stuttgart, NY, 1986, pp. 63-75.